No Matches Found
No Matches Found
No Matches Found
Is InMode Ltd. technically bullish or bearish?
As of October 24, 2025, InMode Ltd. shows a neutral trend with mixed signals, as it has shifted from mildly bullish to sideways, underperforming the S&P 500 with a year-to-date return of -8.32% compared to the index's 15.47%.
Is InMode Ltd. technically bullish or bearish?
As of October 24, 2025, InMode Ltd.'s technical trend is neutral with mixed signals, showing mildly bullish indicators on MACD and KST but mildly bearish trends on moving averages and Dow Theory, indicating a lack of clear direction.
Is InMode Ltd. technically bullish or bearish?
As of October 24, 2025, InMode Ltd.'s technical trend is neutral with mixed indicators, showing mildly bullish signals on weekly and monthly MACD but a mildly bearish sentiment on daily moving averages, while it has underperformed the S&P 500 with a year-to-date return of -8.32% compared to the S&P's 15.47%.
InMode Ltd. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Challenges
InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has seen fluctuations in its stock price, currently at $15.23. The company has faced challenges over the past year, with significant underperformance compared to the S&P 500, reflecting a competitive market environment.
Is InMode Ltd. technically bullish or bearish?
As of October 3, 2025, InMode Ltd. shows a neutral trend with mixed technical indicators, mildly bullish on weekly and monthly MACD and KST, but has underperformed the S&P 500 year-to-date and over the past year, suggesting a cautious investment approach.
Is InMode Ltd. technically bullish or bearish?
As of October 3, 2025, InMode Ltd. shows a neutral trend with mixed signals, being mildly bullish on weekly indicators but bearish on daily moving averages, and has underperformed year-to-date with a -9.28% return compared to the S&P 500's 14.18%.
Is InMode Ltd. technically bullish or bearish?
As of October 3, 2025, InMode Ltd. shows a neutral technical trend with mixed signals, underperforming the S&P 500 year-to-date at -9.28% versus 14.18% and over three years at -49.88% versus 82.57%.
InMode Ltd. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators
InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has seen a slight stock price increase to $15.01. Over the past year, it has struggled with a return of -13.83%, significantly underperforming the S&P 500. Technical indicators show mixed signals, reflecting caution in the short-term outlook.
Is InMode Ltd. technically bullish or bearish?
As of September 19, 2025, InMode Ltd. shows a mildly bearish trend, with daily moving averages indicating bearishness and underperformance against the S&P 500, having a year-to-date return of -10.12% compared to the index's 13.31%.
Is InMode Ltd. technically bullish or bearish?
As of September 19, 2025, InMode Ltd. shows a mildly bearish technical trend, with daily moving averages and monthly Bollinger Bands indicating weakness, while it has underperformed the S&P 500 with year-to-date and one-year returns of -11.98% and -17.14%, respectively.
Is InMode Ltd. technically bullish or bearish?
As of September 12, 2025, InMode Ltd. is in a mildly bearish trend, underperforming the S&P 500 with year-to-date and one-year returns of -9.16% and -13.12%, respectively, despite some mildly bullish indicators.
Is InMode Ltd. overvalued or undervalued?
As of July 30, 2025, InMode Ltd. has a very attractive valuation with a low P/E ratio of 7 and a PEG ratio of 0.40, but it has underperformed the S&P 500 with a year-to-date return of -9.16% and a 3-year return of -51.36%.
InMode Ltd. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators
InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has experienced a slight stock price increase but has struggled over the past year, with a return of -12.79%. Technical indicators show mixed signals, reflecting ongoing challenges in a competitive market environment.
Is InMode Ltd. overvalued or undervalued?
As of May 2, 2024, InMode Ltd. is considered undervalued with a P/E ratio of 7 and strong financial metrics, making it an attractive investment opportunity despite a year-to-date stock decline of 19.22%.
Is InMode Ltd. technically bullish or bearish?
As of June 18, 2025, InMode Ltd. is in a bearish trend with moderate strength, driven by bearish indicators such as the weekly MACD and daily moving averages, despite some mildly bullish signals on the monthly MACD and OBV.
Who are in the management team of InMode Ltd.?
As of March 2022, the management team of InMode Ltd. includes Mr. Moshe Mizrahy as Chairman and CEO, Dr. Michael Kreindel as Chief Technology Officer, and independent directors Dr. Michael Anghel, Mr. Bruce Mann, and Dr. Hadar Ron.
What does InMode Ltd. do?
InMode Ltd. is an Israeli company that develops and commercializes minimally-invasive surgical aesthetic and medical treatment solutions. As of March 2025, it reported net sales of $78 million and a net profit of $18 million, with a market cap of approximately $1.17 billion.
How big is InMode Ltd.?
As of Jun 18, InMode Ltd. has a market capitalization of 1,170.99 million, with net sales of 392.40 million and net profit of 175.78 million over the latest four quarters. As of Dec 24, shareholder's funds are 703.81 million and total assets are 785.67 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
